MedPath
HSA Approval

AXCEL FUSIDIC ACID CREAM 2.0% w/w

SIN14677P

AXCEL FUSIDIC ACID CREAM 2.0% w/w

AXCEL FUSIDIC ACID CREAM 2.0% w/w

November 24, 2014

KOTRA PHARMA MARKETING

KOTRA PHARMA MARKETING

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantKOTRA PHARMA MARKETING
Licence HolderKOTRA PHARMA MARKETING

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CREAM

TOPICAL

Medical Information

D06AX01

fusidic acid

Manufacturer Information

KOTRA PHARMA MARKETING

KOTRA PHARMA (M) SDN BHD

Active Ingredients

FUSIDIC ACID

20 mg/g

Fusidic acid

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AXCEL FUSIDIC ACID CREAM 2.0% w/w - HSA Approval | MedPath